Wells Fargo’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Wells Fargo’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-44,465	Closed	-$1.6M	–	7741
2020 Q4	$1.6M	Buy	44,465 +2,257	+5%	+$79.1K	﹤0.01%	3651
2020 Q3	$1.19M	Sell	42,208 -8,782	-17%	-$311K	﹤0.01%	3723
2020 Q2	$2.21M	Buy	50,990 +35,455	+228%	+$1.61M	﹤0.01%	3193
2020 Q1	$590K	Buy	15,535 +10,666	+219%	+$416K	﹤0.01%	3923
2019 Q4	$0	Buy	+4,869	New	+$123K	﹤0.01%	6932

Wells Fargo's VIE Position: Q1 2021 in Review

Wells Fargo sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 44,465 shares — an estimated $1.6M sold.

Wells Fargo first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $2.21M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Wells Fargo reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Wells Fargo sold 44,465 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $1.6M.
Wells Fargo first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Wells Fargo's Viela Bio, Inc. Common Stock position peaked at $2.21M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.